share_log

Where Insulet Stands With Analysts

Where Insulet Stands With Analysts

Insulet 在分析師眼中的立場
Benzinga ·  05/30 20:00
In the last three months, 6 analysts have published ratings on Insulet (NASDAQ:PODD), offering a diverse range of perspectives from bullish to bearish.
在過去的三個月中,有6位分析師公佈了對Insulet(納斯達克股票代碼:PODD)的評級,提供了從看漲到看跌的不同視角。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級,展示了過去30天內不斷變化的情緒,並將其與前幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $223.67, a high estimate of $260.00, and a low estimate of $200.00. Highlighting a 1.9% decrease, the current average has fallen from the previous average price target of $228.00.
分析師評估的12個月目標股價揭示了進一步的見解,平均目標價爲223.67美元,最高估計爲260.00美元,低估值爲200.00美元。當前的平均價格已從之前的228.00美元的平均目標股價有所下降,這凸顯了1.9%的跌幅。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析師評級:詳細明細
An in-depth analysis of recent analyst actions unveils how...
對分析師近期行爲的深...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論